344 related articles for article (PubMed ID: 1349850)
1. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
[TBL] [Abstract][Full Text] [Related]
2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
3. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas.
Willert JR; Daneshvar L; Sheffield VC; Cogen PH
Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas.
Wu JK; Darras BT
Neurol Res; 1992 Mar; 14(1):39-44. PubMed ID: 1351257
[TBL] [Abstract][Full Text] [Related]
7. p53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms.
al-Sarraj S; Bridges LR; Cawkwell L; Lewis FA; Quirke P
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):344-51. PubMed ID: 7494603
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
10. TP53 gene mutations and 17p deletions in human astrocytomas.
Chung R; Whaley J; Kley N; Anderson K; Louis D; Menon A; Hettlich C; Freiman R; Hedley-Whyte ET; Martuza R
Genes Chromosomes Cancer; 1991 Sep; 3(5):323-31. PubMed ID: 1686725
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
13. Timing of p53 mutations during astrocytoma tumorigenesis.
del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M
Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922
[TBL] [Abstract][Full Text] [Related]
14. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
15. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
16. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors.
Wu JK; Ye Z; Darras BT
Neurosurgery; 1993 Nov; 33(5):824-30; discussion 830-1. PubMed ID: 7903434
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations associated with glioma progression.
Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p53 gene mutations in human endometrial carcinomas.
Honda T; Kato H; Imamura T; Gima T; Nishida J; Sasaki M; Hoshi K; Sato A; Wake N
Int J Cancer; 1993 Apr; 53(6):963-7. PubMed ID: 8473053
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M
Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
